"Stem cell" and "exosome" are two of the most searched terms in regenerative medicine, and they are often used loosely. This guide explains what each one is, what research does and does not show for joint pain, and the questions worth asking any provider in Boise or elsewhere before you decide.

Key takeaways

  • Stem cells are living cells; exosomes are tiny vesicles released by cells. They are different things.
  • Research on both for joint pain is active, but human evidence is early, limited and mixed.
  • FDA guidance encourages patients to confirm whether a regenerative product is FDA-approved for their specific condition.
  • A careful evaluation, honest discussion of alternatives and clear answers about the product matter more than a label.

What is stem cell therapy?

MedlinePlus describes stem cells as cells with the potential to develop into many different types of cells in the body. Their most established medical use is a bone marrow or stem cell transplant for certain blood cancers and blood disorders.

Outside of that setting, "stem cell therapy" can describe many different products, prepared in different ways. FDA patient guidance explains that, generally, stem cell products require FDA approval, and that the stem cell products it has approved are blood-forming cells used for disorders that affect blood production. Its consumer alert on regenerative medicine products adds that the unapproved products it describes have not been approved to treat any orthopedic condition. That is why it is worth asking about approval status for your exact condition.

What are exosomes, and how do they differ from stem cells?

Exosomes are a type of extracellular vesicle: a tiny, membrane-bound packet, about 100 nanometers across, that cells release. A 2020 review in Science explains that they can carry proteins, lipids and genetic material reflecting the cell they came from, which is why researchers study them as a way cells communicate. Unlike stem cells, exosomes are not living cells and cannot divide.

The FDA's public safety notification on exosome products states that there are currently no FDA-approved exosome products and that exosomes used to treat disease are regulated as drugs and biological products. FDA issued that notice after reports of serious adverse events in patients who received unapproved exosome products.

What does the evidence show for joint pain?

Interest is real, and so are the open questions. For exosomes, most joint research is still in the laboratory. A 2025 meta-analysis of 28 studies in rats with knee osteoarthritis found improved cartilage scores under the microscope, and its authors called for more high-quality animal and clinical trials before conclusions can be drawn for people.

For cell-based injections, human trials exist but results are mixed. A 2023 randomized trial in Nature Medicine enrolled 480 people with knee osteoarthritis and compared three types of cell-based injections with a standard corticosteroid injection. At one year, none of the cell-based options was superior to the steroid injection for pain, and no procedure-related serious adverse events were reported. A summary of the American College of Rheumatology and Arthritis Foundation guideline also notes that the guideline recommends against stem cell injections for knee and hip osteoarthritis, citing safety concerns and a lack of demonstrated benefit.

None of this means every product or condition has been studied in the same way. It does mean that confident promises about rebuilding a joint are not supported by current evidence, and that an individual evaluation should come before any decision.

Why does FDA status matter when you compare options?

FDA's patient guidance says it has received reports of serious harms, including blindness, tumor formation and infections, linked to unapproved regenerative products. It also notes that a company's registration with FDA does not mean a product is approved or legally marketed. A useful rule of thumb from that guidance is simple: ask whether the product is FDA-approved for your condition, and if the answer is no or unclear, ask why it is being recommended and what the alternatives are.

If you ever have a problem after a regenerative treatment, FDA encourages reporting it to its MedWatch adverse event program.

What questions should you ask any provider?

  • What exactly is the product, and where does it come from?
  • Is it FDA-approved for my condition? If not, how is it regulated?
  • What studies support it for my diagnosis, and how strong is that evidence?
  • What are the risks, and who do I contact if something goes wrong?
  • What is the total cost, and which standard options should I consider first or alongside it?

For more on diagnosis, preparation and follow-up, see our questions to ask before regenerative joint treatment.

How can Cultiv8 help you sort through your options in Boise?

Cultiv8 Health is a nurse practitioner-led clinic in Boise that offers joint pain evaluations and regenerative joint care. A visit starts with your history, prior care and goals, and our team will explain whether regenerative care, another option or a referral to a different clinician makes the most sense. We are happy to answer every question on the list above about anything we recommend. Individual results vary, and no outcome is guaranteed.

Frequently asked questions

Is exosome therapy FDA-approved?

FDA states that there are currently no FDA-approved exosome products, and that exosomes used to treat disease are regulated as drugs and biological products.

Are stem cells and exosomes the same thing?

No. Stem cells are living cells that can develop into other cell types. Exosomes are tiny vesicles that cells release; they are not cells and cannot divide.

Is a regenerative injection a substitute for joint surgery?

It should not be viewed as one. Evidence for regenerative injections in joints is still limited, and some conditions need a surgical opinion. An evaluation can help you understand the full range of options.

What should I bring to a first conversation about regenerative care?

Bring a summary of your symptoms, prior diagnoses, imaging, injections or therapy you have tried, and a list of current medicines and supplements, along with the questions you most want answered.

Talk with a Boise provider about your joint pain

If you are weighing stem cell, exosome or other regenerative options for knee, shoulder, hip or tendon pain, start with a clear conversation. Book your free regenerative medicine discovery session. Call or text 208.908.0988, or visit us at 3050 N Lakeharbor Ln Ste 120, Boise, ID 83703. Please do not include sensitive medical details in the website form.

Sources